Registry-based study of survivorship of cemented femoral components versus collared cementless femoral components in total hip arthroplasty in older patients with osteoarthritis

医学 假肢 骨关节炎 置信区间 距 关节置换术 危险系数 外科 植入 牙科 内科学 病理 替代医学
作者
Aida Orce Rodríguez,Paul N. Smith,Paul Johnson,Michael O’Sullivan,Carl Holder,Andrew Shimmin
出处
期刊:The bone & joint journal [British Editorial Society of Bone & Joint Surgery]
卷期号:106-B (3 Supple A): 121-129 被引量:18
标识
DOI:10.1302/0301-620x.106b3.bjj-2023-0771.r1
摘要

Aims In recent years, the use of a collared cementless femoral prosthesis has risen in popularity. The design intention of collared components is to transfer some load to the resected femoral calcar and prevent implant subsidence within the cancellous bone of the metaphysis. Conversely, the load transfer for a cemented femoral prosthesis depends on the cement-component and cement-bone interface interaction. The aim of our study was to compare the three most commonly used collared cementless components and the three most commonly used tapered polished cemented components in patients aged ≥ 75 years who have undergone a primary total hip arthroplasty (THA) for osteoarthritis (OA). Methods Data from the Australian Orthopaedic Association National Joint Replacement Registry from 1 September 1999 to 31 December 2022 were analyzed. Collared cementless femoral components and cemented components were identified, and the three most commonly used components in each group were analyzed. We identified a total of 11,278 collared cementless components and 47,835 cemented components. Hazard ratios (HRs) from Cox proportional hazards models, adjusting for age and sex, were obtained to compare the revision rates between the groups. Results From six months postoperatively onwards, patients aged ≥ 75 years undergoing primary THA with primary diagnosis of OA have a lower risk of all-cause revision with collared cementless components than with a polished tapered cemented component (HR 0.78 (95% confidence interval 0.64 to 0.96); p = 0.018). There is no difference in revision rate prior to six months. Conclusion Patients aged ≥ 75 years with a primary diagnosis of OA have a significantly lower rate of revision with the most common collared cementless femoral component, compared with the most common polished tapered cemented components from six months postoperatively onwards. The lower revision rate is largely due to a reduction in revisions for fracture and infection. Cite this article: Bone Joint J 2024;106-B(3 Supple A):121–129.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
隐形曼青的应助被于特采纳,获得10
刚刚
下论文发布了新的文献求助10
1秒前
月儿发布了新的文献求助10
1秒前
红叶发布了新的文献求助20
2秒前
顺心尔风完成签到,获得积分10
2秒前
李谢谢发布了新的文献求助10
2秒前
2秒前
3秒前
3秒前
4秒前
alexlpb发布了新的文献求助10
4秒前
5秒前
懒癌晚期完成签到,获得积分10
5秒前
魔修完成签到,获得积分10
6秒前
elaine完成签到,获得积分10
6秒前
明理冬瓜完成签到,获得积分10
6秒前
上官若男的应助被LYY采纳,获得10
6秒前
7秒前
王达达完成签到 ,获得积分10
7秒前
didihe发布了新的文献求助10
8秒前
冷艳紫南完成签到,获得积分10
8秒前
粗犷的沛容完成签到,获得积分0
9秒前
qqq发布了新的文献求助10
9秒前
9秒前
9秒前
下论文完成签到,获得积分10
9秒前
10秒前
bkagyin的应助被大鹅采纳,获得10
10秒前
jjleborn完成签到,获得积分10
10秒前
zezer完成签到,获得积分10
11秒前
纯情的馒头完成签到,获得积分10
12秒前
may完成签到 ,获得积分10
13秒前
Orange的应助被红叶采纳,获得10
13秒前
小易发布了新的文献求助10
14秒前
隔壁小孩发布了新的文献求助10
14秒前
15秒前
BingyuLi完成签到,获得积分10
15秒前
15秒前
15秒前
田様的应助被科研通管家采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
Recombinant human Type III collagen with native-like assembly and real biomaterial performance 1000
CLSI VET01S Ed7 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals 1000
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre (2012-09-10) 666
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7874151
求助须知:如何正确求助?哪些是违规求助? 9390006
关于积分的说明 20779626
捐赠科研通 7475624
什么是DOI,文献DOI怎么找? 3351974
关于科研通互助平台的介绍 2492700
邀请新用户注册赠送积分活动 2378884